KleinHUBennettDADe JagerPL.The epigenome in Alzheimer’s disease: Current state and approaches for a new path to gene discovery and understanding disease mechanism. Acta Neuropathol2016; 132(4): 503–514.
4.
De JagerPLSrivastavaGLunnonKet al. Alzheimer’s disease: Early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci2014; 17(9): 1156–1163.
5.
OlssonTBarcellosLFAlfredssonL.Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol2017; 13(1): 25–36.
6.
NgBWhiteCCKleinHUet al. An xQTL map integrates the genetic architecture of the human brain’s transcriptome and epigenome. Nat Neurosci2017; 20: 1418–1426.
7.
MengWZhuZJiangXet al. DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis. Arthritis Res Ther2017; 19(1): 71–80.
8.
BaranziniSEMudgeJvan VelkinburghJCet al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature2010; 464(7293): 1351–1356.
9.
GravesMCBentonMLeaRAet al. Methylation differences at the HLA-DRB1 locus in CD4+ T-cells are associated with multiple sclerosis. Mult Scler2014; 20(8): 1033–1041.
10.
MaltbyVEGravesMCLeaRAet al. Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients. Clin Epigenetics2015; 7: 118
11.
HuynhJLGargPThinTHet al. Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains. Nat Neurosci2014; 17(1): 121–130.
12.
DawsonMA.The cancer epigenome: Concepts, challenges, and therapeutic opportunities. Science2017; 355(6330): 1147–1152.
